Thomas Graney
Independent External DirectorMr. Thomas Graney, also known as Tom, C.F.A., is Independent External Director at Notable Labs, Ltd since October 16, 2023. He was a Non-Executive Director at Mogrify Limited since November 2021. He served as Director at Oxurion NV since August 2021 until December 2023. He served as Chief Financial Officer of Oxurion NV since October 14, 2020 until December 2023 and served as its Chief Executive Officer since May 15, 2021 until December 2023. He served as Chief Financial Officer at Generation Bio Co. since February 21, 2019 until April 2020. Mr. Graney served as Executive of Vertex Pharmaceuticals Incorporated since September 13, 2017. Prior to Generation Bio, Mr. Graney served as a Chief Financial Officer and Senior Vice President of Vertex Pharmaceuticals Incorporated from September 13, 2017 to December 13, 2018. Mr. Graney is responsible for the development and execution of the financial strategy and operations that support Vertex's business plans, including the Finance, Accounting and Internal Audit functions. Prior to Vertex, he served as Chief Financial Officer and Senior Vice President of Finance & Corporate Strategy at Ironwood Pharmaceuticals, Inc. since September 2014 until September 13, 2017. He was responsible for Finance, Corporate Strategy, Corporate Development, Quality, Supply Chain, IT, Corporate Communications and Investor Relations at Ironwood Pharmaceuticals. Prior to joining Ironwood Pharmaceuticals in 2014, he worked at Johnson & Johnson in both the U.S. and abroad. Mr. Graney served as worldwide Vice President of Finance and Chief Financial Officer of Ethicon Surgical Care at Johnson & Johnson (J&J) company. Earlier in his career he spent years with Johnson and Johnson, including CFO roles at Ethicon, Tibotec and Janssen. He was VP and CFO of Janssen Pharmaceuticals NA, a major pharmaceutical company in North America. He has experience in senior finance, strategy and operational roles including capital raising, accounting and audit. He served as Independent Non-Executive Director at AC Immune SA since November 15, 2016 until June 23, 2023 and serves as Director since October 2, 2026. A Chartered Financial Analyst charter holder, Mr. Graney holds a B.S. in Accounting from the University of Delaware and an M.B.A. in Marketing, Finance and International Business from the Leonard N. Stern School of Business at New York University.
Positions
- Company NameNotable Labs, Ltd.Stock CodeNTBLQPositionIndependent External DirectorColleagues
- SAScott Alan McPhersonChief Financial Officer
- TPTuomo PatsiIndependent Chairman
- JPJoseph P. WagnerChief Scientific Officer
- KZKaile ZaggerInterim CEO & Chief Restructuring Officer
- GCGlenn C. MichelsonChief Medical Officer
- TIThomas I. H. DubinIndependent External Director
- PFPeter FeinbergIndependent Director
- MGMichele GalenIndependent Director
